Skip to main content
    C

    Cross Country Healthcare Inc (CCRN)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $13.25
    +0.00 (+0.00%)

    Market Cap: $428.06M

    Last updated: Jul 22, 2026 at 5:00 PM ET

    Cross Country Healthcare Inc (CCRN) Financials: Revenue, Profit and Cash Flow

    Updated May 7, 2026. Financial statements from company filings, amounts in US dollars.

    Cross Country Healthcare reported revenue of $1.05B for the fiscal year ended Dec 31, 2025, down 21.6% from the year before. That year, net income was -$94.85M with a net margin of -9.0%, operating cash flow was $48.25M and free cash flow was $40.09M. The quarter ended Mar 31, 2026 had revenue of $241.06M and net income of -$4.27M.

    Revenue and Margins

    The operating margin was -8.0% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $833.54M, a compound annual rate of 2.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.05B-21.6%20.3%-8.0%-9.0%
    Dec 2024$1.34B-33.5%98.4%-1.3%-1.1%
    Dec 2023$2.02B-28.0%99.3%5.6%3.6%
    Dec 2022$2.80B+67.2%99.7%9.6%6.6%
    Dec 2021$1.68B+100.5%22.4%8.3%7.9%
    Dec 2020$836.42M+1.7%99.6%-1.1%-1.5%
    Dec 2019$822.22M+0.7%99.8%-1.9%-6.8%
    Dec 2018$816.48M-5.6%99.7%-1.6%-1.9%
    Dec 2017$865.05M+3.8%99.8%1.4%4.5%
    Dec 2016$833.54MN/A99.9%0.7%1.0%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Mar 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.05B$1.34B$2.02B$2.80B$1.68B$836.42M$822.22M$816.48M$865.05M$833.54M
    Cost of revenue$840.72M$21.43M$14.56M$9.61M$1.30B$3.04M$2.01M$2.20M$1.83M$593.00K
    Gross profit$213.57M$1.32B$2.01B$2.79B$375.00M$833.38M$820.22M$814.28M$863.22M$832.94M
    Operating income-$84.41M-$16.86M$112.71M$269.88M$139.30M-$9.16M-$15.71M-$12.88M$11.75M$6.18M
    Net income-$94.85M-$14.56M$72.63M$185.98M$132.00M-$12.14M-$55.94M-$15.72M$38.80M$8.73M
    EBITDA-$67.63M$1.94M$130.97M$283.78M$149.93M$3.23M-$2.85M-$682.00K$24.31M$23.13M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Revenue$241.06M$236.76M$250.05M$274.07M$293.41M$309.94M$315.12M$339.77M$379.17M$414.04M$442.29M$540.70M
    Gross profit$241.00M-$604.76M$250.91M$274.04M$293.37M$310.17M$313.61M$320.91M$377.88M$409.87M$439.94M$537.56M
    Operating income-$4.16M-$71.61M-$5.97M-$5.86M-$977.00K-$3.43M$2.85M-$19.21M$2.92M$13.42M$20.30M$35.19M
    Net income-$4.27M-$82.93M-$4.77M-$6.66M-$490.00K-$3.75M$2.56M-$16.05M$2.69M$9.04M$12.81M$21.34M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $1.16M by $107.58M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$448.95M$589.25M$681.06M$949.59M$732.81M$356.97M$382.37M$427.00M$467.69M$388.38M
    Current assets$293.59M$335.00M$416.88M$677.39M$508.27M$183.11M$183.36M$194.91M$208.89M$205.61M
    Cash and equivalents$108.74M$81.63M$17.09M$3.60M$1.04M$1.60M$1.03M$16.02M$25.54M$20.63M
    Total liabilities$126.13M$170.29M$213.41M$498.11M$435.28M$202.06M$218.87M$208.81M$229.97M$236.58M
    Short-term debt$1.16M$4.41M$6.79M$7.50M$11.68M$2.42M$4.88M$5.24M$6.88M$2.25M
    Long-term debtN/AN/AN/A$148.74M$176.37M$53.41M$70.97M$77.94M$92.26M$84.75M
    Shareholder equity$322.82M$418.96M$467.65M$451.48M$297.53M$154.38M$162.63M$217.53M$237.09M$151.24M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total assets$451.07M$448.95M$538.23M$553.82M$576.24M$589.25M$597.42M$602.88M$648.44M$679.32M$707.74M$771.13M
    Total liabilities$138.27M$126.13M$130.09M$141.58M$158.03M$170.29M$172.73M$163.82M$180.25M$205.92M$238.08M$300.78M
    Cash and equivalents$105.58M$108.74M$99.13M$81.19M$80.70M$81.63M$64.02M$69.60M$5.24M$17.09M$14.30M$673.00K
    Shareholder equity$312.81M$322.82M$408.14M$412.24M$418.21M$418.96M$424.69M$439.06M$468.19M$473.39M$469.66M$470.35M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 83.1% of operating cash flow. Share repurchases came to 17.0% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$48.25M$120.12M$248.50M$134.05M-$85.62M$27.20M$5.54M$21.00M$45.51M$30.14M
    Capital expenditures$8.16M$8.71M$13.97M$8.79M$7.17M$4.62M$2.94M$4.60M$5.11M$6.52M
    Free cash flow$40.09M$111.40M$234.52M$125.26M-$92.79M$22.59M$2.60M$16.40M$40.40M$23.62M
    Dividends paidN/AN/AN/AN/AN/A$1.15M$1.57M$1.19M$1.22M$701.00K
    Share repurchases$6.83M$37.31M$57.65M$35.28M$0$0N/A$5.00M$0$0
    Investing cash flow-$8.16M-$8.71M-$13.78M-$43.87M-$34.05M-$4.62M-$2.94M-$6.68M-$91.38M-$9.78M
    Financing cash flow-$13.01M-$46.85M-$221.24M-$87.60M$119.09M-$22.01M-$17.60M-$23.77M$50.76M-$2.16M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Operating cash flow$4.77M$18.24M$20.11M$4.22M$5.68M$24.23M$7.47M$82.40M$6.01M$12.07M$70.31M$119.25M
    Capital expenditures$1.46M$2.12M$2.19M$1.97M$1.89M$2.53M$1.12M$2.85M$2.21M$2.88M$3.42M$4.00M
    Free cash flow$3.31M$16.12M$17.92M$2.25M$3.79M$21.70M$6.35M$79.55M$3.80M$9.20M$66.89M$115.25M
    Last 12 quarters

    Frequently Asked Questions About CCRN

    What is Cross Country Healthcare's annual revenue?

    Cross Country Healthcare reported revenue of $1.05B for the fiscal year ended Dec 31, 2025.

    How fast is Cross Country Healthcare's revenue growing?

    Revenue was down 21.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -27.8%.

    Is Cross Country Healthcare profitable?

    No. Cross Country Healthcare reported net income of -$94.85M for the fiscal year ended Dec 31, 2025, with a net margin of -9.0%.

    How much free cash flow does CCRN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $48.25M minus capital expenditures of $8.16M produced free cash flow of $40.09M.

    How much debt does Cross Country Healthcare have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $1.16M and cash and equivalents of $108.74M.